Related Experiment Video
Updated: Jul 16, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Upper airway obstruction-related sleep apnea in a child with thalassemia intermedia
J Kapelushnik1, H Shalev, H Schulman
1Department of Pediatric Hemato-Oncology, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Insights
Severe obstructive sleep apnea in a child with thalassemia intermedia was caused by extramedullary hematopoiesis. Treatment with hydroxyurea and blood transfusions improved symptoms, suggesting a potential therapeutic approach.
Area of Science:
- Hematology
- Pediatrics
- Sleep Medicine
Background:
- Obstructive sleep apnea (OSA) commonly results from tonsil/adenoid hypertrophy or neuromuscular disorders.
- Thalassemia intermedia is a genetic blood disorder requiring ongoing management.
Observation:
- A pediatric patient with thalassemia intermedia presented with severe obstructive sleep apnea syndrome.
- Computed tomography revealed nasopharyngeal obstruction due to extramedullary hematopoiesis.
Findings:
- Extramedullary hematopoiesis, a condition where blood cell production occurs outside bone marrow, was identified as the cause of OSA in this thalassemic child.
- Treatment involving hydroxyurea and blood transfusions led to symptom resolution within 1.5 months.
Implications:
- This case highlights extramedullary hematopoiesis as a significant cause of sleep apnea in thalassemic patients.
- Further research into hydroxyurea and blood transfusion therapy for extramedullary hematopoiesis-induced OSA is warranted.
Abstract:
Obstructive sleep apnea can be caused by hypertrophy of tonsils and adenoids or neuromuscular diseases. The authors describe a child with thalassemia intermedia in whom severe obstructive sleep apnea syndrome developed. Computed tomography scanning revealed an obstruction of the nasopharynx resulting from extramedullary hematopoiesis. The child was treated with hydroxyurea and blood transfusions. Relief of symptoms was noted 1.5 months after initial treatment. Extramedullary hematopoiesis causes sleep apnea syndrome in thalassemic patients, and the treatment of hydroxyurea and blood transfusion for extramedullary hematopoiesis should be further studied.
Related Concept Videos
Breathing
Assessment of Airway, Skin Color, and Use of Accessory Muscles
Introduction
The initial evaluation of a patient's respiratory system...
Trachea
Anatomical Features:
Location: About half of the trachea is situated in the neck, anterior to the esophagus, and extends from the larynx (at the level of the...
Other Pulmonary Disorders
Sleep Apnea
The condition is more prevalent among...
Cardiopulmonary Resuscitation II: ACLS Airway Management

